Edwards Lifesciences
1,308 hedge funds and large institutions have $59.5B invested in Edwards Lifesciences in 2022 Q1 according to their latest regulatory filings, with 126 funds opening new positions, 472 increasing their positions, 474 reducing their positions, and 117 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,308
Holders Change
-6
Holders Change %
-0.46%
% of All Funds
20.7%
Holding in Top 10
26
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-3.7%
% of All Funds
0.41%
New
126
Increased
472
Reduced
474
Closed
117
Calls
$289M
Puts
$189M
Net Calls
+$99.6M
Net Calls Change
+$88.1M
Top Buyers
| 1 |
Nuveen Asset Management
Chicago,
Illinois
|
$686M |
| 2 |
Amundi
Paris,
France
|
$658M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
$1.66B |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$5.85B |
| 5 |
CI Investments Inc
Toronto,
Ontario, Canada
|
$246M |
Top Sellers
| 1 |
UBS AM
Chicago,
Illinois
|
$571M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
$1.76B |
| 3 |
Sands Capital Management
Arlington,
Virginia
|
$1.38B |
| 4 |
Barclays
London,
United Kingdom
|
$121M |
| 5 |
Two Sigma Investments
New York
|
$31.1M |
